» Articles » PMID: 27907119

Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

Overview
Journal PLoS One
Date 2016 Dec 2
PMID 27907119
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple sclerosis (MS) has a significant inflammatory component and may have significant gray matter (GM) pathophysiology. Brain oxygenation is a sensitive measurement of the balance between metabolic need and oxygen delivery. There is evidence that inflammation and hypoxia are interdependent. In this paper, we applied novel, implanted PO2 sensors to measure hypoxia in cortical and cerebellar GM, in an inflammation-induced mouse model of MS.

Objective: Quantify oxygenation in cortical and cerebellar GM in the awake, unrestrained experimental autoimmune encephalomyelitis (EAE) mouse model and to relate the results to symptom level and disease time-course.

Methods: C57BL/6 mice were implanted with a fiber-optic sensor in the cerebellum (n = 13) and cortex (n = 24). Animals were induced with stimulation of the immune response and sensitization to myelin oligodendrocyte glycoprotein (MOG). Controls did not have MOG. We measured PO2 in awake, unrestrained animals from pre-induction (baseline) up to 36 days post-induction for EAE and controls.

Results: There were more days with hypoxia than hyperoxia (cerebellum: 34/67 vs. 18/67 days; cortex: 85/112 vs. 22/112) compared to time-matched controls. The average decline in PO2 on days that were significantly lower than time-matched controls was -8.8±6.0 mmHg (mean ± SD) for the cerebellum and -8.0±4.6 for the cortex. Conversely, the average increase in PO2 on days that were significantly hyperoxic was +3.2±2.8 mmHg (mean ± SD) for the cerebellum and +0.8±2.1 for the cortex. Cortical hypoxia related to increased behavioral deficits. Evidence for hypoxia occurred before measurable behavioral deficits.

Conclusions: A highly inflammatory condition primed to a white matter (WM) autoimmune response correlates with significant hypoxia and increased variation in oxygenation in GM of both cerebellum and cortex in the mouse EAE model of MS.

Citing Articles

A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications.

Soroush A, Dunn J Curr Treat Options Neurol. 2024; 27(1):6.

PMID: 39569339 PMC: 11573864. DOI: 10.1007/s11940-024-00816-4.


The neuropathobiology of multiple sclerosis.

Woo M, Engler J, Friese M Nat Rev Neurosci. 2024; 25(7):493-513.

PMID: 38789516 DOI: 10.1038/s41583-024-00823-z.


Delimiting MOGAD as a disease entity using translational imaging.

Oertel F, Hastermann M, Paul F Front Neurol. 2024; 14:1216477.

PMID: 38333186 PMC: 10851159. DOI: 10.3389/fneur.2023.1216477.


Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions.

Maxwell D, Orian J J Cent Nerv Syst Dis. 2023; 15:11795735231211508.

PMID: 37942276 PMC: 10629308. DOI: 10.1177/11795735231211508.


Regional contribution of vascular dysfunction in white matter dementia: clinical and neuropathological insights.

Pansieri J, Hadley G, Lockhart A, Pisa M, DeLuca G Front Neurol. 2023; 14:1199491.

PMID: 37396778 PMC: 10313211. DOI: 10.3389/fneur.2023.1199491.


References
1.
Dalton C, Chard D, Davies G, Miszkiel K, Altmann D, Fernando K . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain. 2004; 127(Pt 5):1101-7. DOI: 10.1093/brain/awh126. View

2.
Brooks D, Leenders K, Head G, Marshall J, Legg N, Jones T . Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1984; 47(11):1182-91. PMC: 1028084. DOI: 10.1136/jnnp.47.11.1182. View

3.
Desai R, Davies A, Tachrount M, Kasti M, Laulund F, Golay X . Cause and prevention of demyelination in a model multiple sclerosis lesion. Ann Neurol. 2016; 79(4):591-604. PMC: 4949637. DOI: 10.1002/ana.24607. View

4.
Cummins E, Berra E, Comerford K, Ginouves A, Fitzgerald K, Seeballuck F . Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A. 2006; 103(48):18154-9. PMC: 1643842. DOI: 10.1073/pnas.0602235103. View

5.
Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292(5516):468-72. DOI: 10.1126/science.1059796. View